These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Protective effect of kava constituents in an in vitro model of oral mucositis. Yiannis C; Huang K; Tran AN; Zeng C; Dao E; Baselyous O; Mithwani MA; Paolini R; Cirillo N; Yap T; McCullough M; Celentano A J Cancer Res Clin Oncol; 2020 Jul; 146(7):1801-1811. PubMed ID: 32435894 [TBL] [Abstract][Full Text] [Related]
3. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in Tang Y; Fields C Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989 [TBL] [Abstract][Full Text] [Related]
4. Flavokawains A and B from kava (Piper methysticum) activate heat shock and antioxidant responses and protect against hydrogen peroxide-induced cell death in HepG2 hepatocytes. Pinner KD; Wales CT; Gristock RA; Vo HT; So N; Jacobs AT Pharm Biol; 2016 Sep; 54(9):1503-12. PubMed ID: 26789234 [TBL] [Abstract][Full Text] [Related]
5. Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro. Abu N; Akhtar MN; Yeap SK; Lim KL; Ho WY; Abdullah MP; Ho CL; Omar AR; Ismail J; Alitheen NB BMC Complement Altern Med; 2016 Feb; 16():86. PubMed ID: 26922065 [TBL] [Abstract][Full Text] [Related]
6. The In Vitro and In Vivo Antiangiogenic Effects of Flavokawain B. Rossette MC; Moraes DC; Sacramento EK; Romano-Silva MA; Carvalho JL; Gomes DA; Caldas H; Friedman E; Bastos-Rodrigues L; De Marco L Phytother Res; 2017 Oct; 31(10):1607-1613. PubMed ID: 28816367 [TBL] [Abstract][Full Text] [Related]
7. The protective effects of Kava (Piper Methysticum) constituents in cancers: A systematic review. Celentano A; Tran A; Testa C; Thayanantha K; Tan-Orders W; Tan S; Syamal M; McCullough MJ; Yap T J Oral Pathol Med; 2019 Aug; 48(7):510-529. PubMed ID: 31172600 [TBL] [Abstract][Full Text] [Related]
8. Kavalactones fail to inhibit alcohol dehydrogenase in vitro. Anke J; Fu S; Ramzan I Phytomedicine; 2006 Feb; 13(3):192-5. PubMed ID: 16428028 [TBL] [Abstract][Full Text] [Related]
9. Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis. Ji T; Lin C; Krill LS; Eskander R; Guo Y; Zi X; Hoang BH Mol Cancer; 2013 Jun; 12():55. PubMed ID: 23764122 [TBL] [Abstract][Full Text] [Related]
10. Flavokawain A induces apoptosis in MCF-7 and MDA-MB231 and inhibits the metastatic process in vitro. Abu N; Akhtar MN; Yeap SK; Lim KL; Ho WY; Zulfadli AJ; Omar AR; Sulaiman MR; Abdullah MP; Alitheen NB PLoS One; 2014; 9(10):e105244. PubMed ID: 25286005 [TBL] [Abstract][Full Text] [Related]
11. Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro. Einbond LS; Negrin A; Kulakowski DM; Wu HA; Antonetti V; Jalees F; Law W; Roller M; Redenti S; Kennelly EJ; Balick MJ Phytomedicine; 2017 Jan; 24():1-13. PubMed ID: 28160848 [TBL] [Abstract][Full Text] [Related]
12. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Zi X; Simoneau AR Cancer Res; 2005 Apr; 65(8):3479-86. PubMed ID: 15833884 [TBL] [Abstract][Full Text] [Related]
14. In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice. Abu N; Mohamed NE; Yeap SK; Lim KL; Akhtar MN; Zulfadli AJ; Kee BB; Abdullah MP; Omar AR; Alitheen NB Drug Des Devel Ther; 2015; 9():1401-17. PubMed ID: 25834398 [TBL] [Abstract][Full Text] [Related]
15. Interaction of various Piper methysticum cultivars with CNS receptors in vitro. Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444 [TBL] [Abstract][Full Text] [Related]
16. Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Backhauss C; Krieglstein J Eur J Pharmacol; 1992 May; 215(2-3):265-9. PubMed ID: 1396990 [TBL] [Abstract][Full Text] [Related]
17. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract. Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149 [TBL] [Abstract][Full Text] [Related]
18. Kava does not display metabolic toxicity in a homogeneous cellular assay. Zou L; Harkey MR; Henderson GL; Dike LE Planta Med; 2004 Apr; 70(4):289-92. PubMed ID: 15095141 [TBL] [Abstract][Full Text] [Related]
19. Effects of kava (Kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes. Zou L; Henderson GL; Harkey MR; Sakai Y; Li A Phytomedicine; 2004; 11(4):285-94. PubMed ID: 15185840 [TBL] [Abstract][Full Text] [Related]
20. Flavokawain B induces apoptosis of human oral adenoid cystic cancer ACC-2 cells via up-regulation of Bim and down-regulation of Bcl-2 expression. Zhao X; Chao YL; Wan QB; Chen XM; Su P; Sun J; Tang Y Can J Physiol Pharmacol; 2011 Dec; 89(12):875-83. PubMed ID: 22115332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]